Literature DB >> 32553882

Electrocardiographic imaging of the arrhythmogenic substrate of Brugada syndrome: Current evidence and future perspectives.

Alessio Galli1, Alessandro Rizzo1, Cinzia Monaco1, Francesca Salghetti1, Oriana Scala1, Gian Battista Chierchia1, Mark La Meir2, Pedro Brugada1, Carlo de Asmundis3.   

Abstract

Brugada syndrome is responsible for about 20% of sudden cardiac deaths in patients with apparently normal hearts. Basic and clinical research has elucidated some of the mechanisms that are responsible for life-threatening ventricular arrhythmias in this syndrome. Delays in activation and repolarization over the right ventricular outflow tract are the most likely cause of the ECG typical pattern and arrhythmogenesis. Invasive epicardial and endocardial mapping has identified the epicardium as the principal region of interest for these anomalies, and areas of fragmented potentials at invasive mapping are a target for epicardial ablation. Noninvasive mapping systems have been developed to study the epicardial depolarization and repolarization and may be particularly useful in assessing the epicardial arrhythmogenic substrate of Brugada syndrome for both clinical and research purpose. This review focuses on recent advances in this field.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Arrhythmias; Brugada syndrome; ECGi; Noninvasive mapping

Year:  2020        PMID: 32553882     DOI: 10.1016/j.tcm.2020.06.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  1 in total

Review 1.  Ablation therapy of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and primary electrical diseases: new insights in invasive treatment options in severely symptomatic patients.

Authors:  Cinzia Monaco; Antonio Sorgente; Robbert Ramak; Gian Battista Chierchia; Mark La Meir; Carlo de Asmundis
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.